Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
Part of paid clinical trials in Charlotte, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT07175376
- Status
- Recruiting
Conditions
- Cancer
- Chemotherapy
- Frail
Eligibility Criteria
- Sex
- ALL
- Age
- 65 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Supportive Care — OTHERGeriatric assessment (GA) -guided supportive care and weekly Patient Reported Outcomes (PRO) symptom assessment
Study Details
The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.
Key Dates
- Start date
- Mar 16, 2026
- Status verified
- Jan 2026
- Primary completion
- Jan 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 32 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Participants 65 years or older with active cancer diagnosis and planned chemotherapyParticipants aged 65 or older with an active cancer diagnosis who are planned to receive chemotherapy and are eFI pre-frail or frail. Participants will be provided with results and education regarding baseline assessments and offered referrals for supportive care interventions to decrease chemotherapy toxicity
Primary Outcome Measure
Recruitment rate [ Time Frame: Enrollment ]
Central Contacts
- James Morgan336-702-4491
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | |
| Atrium Health Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | North Carolina | 27157 | Heidi Klepin, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Charlotte, NC
Related Studies
- Study of the Effect of Innate on the Inflammatory Response to EndotoxinRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Research Triangle Park, North Carolina
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Pan Tumor Rollover StudyPHASE2 · Recruiting · Bristol-Myers Squibb · Huntsville, Alabama
- Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19Enrolling By Invitation · Duke University · Durham, North Carolina